tirzepatide semaglutide efficacy side effects vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Weighing up the Risks: GI

Storage requirements for tirzepatide are straightforward

The SURMOUNT-4 follow-up analysis, published in JAMA Internal Medicine in 2025, found that weight regain after stopping tirzepatide was associated with reversal of improvements in blood pressure, blood glucose, cholesterol, and insulin sensitivity

Month 2 through 3: near-normal energy By the second month, the majority of users report energy levels at 85% to 95% of their pre-treatment baseline

With full treatment adherence, participants taking oral semaglutide 25 mg daily achieved 16.6% mean weight loss at 64 weeks, compared to 2.7% with placebo

Friedman does not directly dispense these compounds

early metabolic improvements are promising, but definitive cardiovascular risk-reduction data were not established at the time of this writing